Lancaster General Ann B Barshinger Cancer Institute is a clinical research site located in Lancaster, Pennsylvania, United States 17601.
Crixeo Clinical Trials Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Lancaster General Ann B Barshinger Cancer Institute has participated in 20 clinical trials with 18 currently active.
Therapeutic areas: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.
Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lancaster General Ann B Barshinger Cancer Institute has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lancaster General Ann B Barshinger Cancer Institute has 20 clinical trials on record, with 18 currently active. Their work covers Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8.
Lancaster General Ann B Barshinger Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.